✦ LIBER ✦

A randomized controlled trial of ciamexon versus placebo in the immunomodulatory treatment of rheumatoid arthritis

✍ Scribed by Christoph Baerwald; Klaus-M. Goebel; Andreas Krause; Jochen Heymanns

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 501 KB
Volume: 33
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780330517

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gamma-linolenic acid treatment of rheuma

Gamma-linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial

✍ Robert B. Zurier; Ronald G. Rossetti; Eric W. Jacobson; Deborah M. Demarco; Nanc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 971 KB

Treatment of early Rheumatoid Arthritis

Treatment of early Rheumatoid Arthritis with minocycline or placebo. Results of a Randomized, double-blind, placebo-controlled trial

✍ James R. O'Dell; Claire E. Haire; William Palmer; Walter Drymalski; Steven Wees; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 692 KB

Treatment of rheumatoid arthritis with a

Treatment of rheumatoid arthritis with a syk kinase inhibitor: A twelve-week, randomized, placebo-controlled trial

✍ Michael E. Weinblatt; Arthur Kavanaugh; Ruben Burgos-Vargas; Ara H. Dikranian; G 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

## Abstract ## Objective Spleen tyrosine kinase (Syk) has been identified as an important modulator of immune signaling in B cells and cells bearing Fcγ‐activating receptors. R788, a prodrug of active metabolite R406, has been shown to be an inhibitor of Syk kinase, active in a variety of in vitro

Efficacy of methotrexate treatment in pa

Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial

✍ Henrike van Dongen; Jill van Aken; Leroy R. Lard; Karen Visser; H. Karel Ronday; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex

Oral type II collagen treatment in early

Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial

✍ Joachim Sieper; Sonja Kary; Helmut Sörensen; Rieke Alten; Ulrich Eggens; Werner 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 951 KB

A randomized, placebo-controlled trial o

A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis

✍ Nicolino Ruperto; Daniel J. Lovell; Ruben Cuttica; Nick Wilkinson; Patricia Woo; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## Abstract ## Objective To evaluate the safety and efficacy of infliximab in the treatment of juvenile rheumatoid arthritis (JRA). ## Methods This was an international, multicenter, randomized, placebo‐controlled, double‐blind study. One hundred twenty‐two children with persistent polyarticular